Fundz

Lyell Immunopharma, Inc. reported raising $493 Million in an initial SEC Form D filing, from an offering of $493 Million

PUBLIC · LYELMar 20, 2020

Amount Raised

$493 Million

$493 Million sold, per SEC Form D (first sale Mar 20, 2020)

Round Type

Venture

South San FranciscoBiotechnologyHealth CareTherapeutics

Quick answer

Lyell Immunopharma raised $493 Million in a funding round, dated March 20, 2020. Lyell Immunopharma is based in South San Francisco, California, United States.

How much did Lyell Immunopharma raise?
Lyell Immunopharma raised $493 Million in a funding round on March 20, 2020.
What does Lyell Immunopharma do?
Lyell Immunopharma, Inc. is a clinical-stage biotechnology company specializing in next-generation cell therapies for cancer patients.
Where is Lyell Immunopharma based and how big is it?
Lyell Immunopharma is based in South San Francisco, California, United States. Fundz records about 279 employees.
Who are the decision-makers at Lyell Immunopharma?
Fundz holds 5 contacts at Lyell Immunopharma. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Lyell Immunopharma that raised within 45 days of this round, from Fundz verified event records.

  • Alpha Cognition raised $1.9M (Seed) on May 1, 2020.
  • Os Therapies raised an undisclosed amount on May 1, 2020.
  • Fate Therapeutics raised $50M on April 21, 2020.
  • Phio Pharmaceuticals raised $4.4M on April 14, 2020.
  • Crispr Therapeutics raised $1M (Seed) on April 9, 2020.
  • Legend Biotech raised $150M on April 7, 2020.

Who to call at Lyell Immunopharma, and when

A new round usually means Lyell Immunopharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Lyell Immunopharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lyell Immunopharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lyell Immunopharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lyell Immunopharma

Location

400 EAST JAMIE COURT

South San Francisco, California, United States

About

Lyell Immunopharma, Inc. is a clinical-stage biotechnology company specializing in next-generation cell therapies for cancer patients. It is publicly listed on Nasdaq under the symbol LYEL. The company aims to bring meaningful and durable clinical benefit to patients by focusing on next-generation CAR T-cell therapies and proprietary technologies designed to generate longer-lasting, functional T cells to achieve more durable outcomes for patients with solid tumors and hematologic malignancies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lyell Immunopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

5 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Lyell Immunopharma's next move

See what Strategic adds

Lyell Immunopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.